89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Stock Titan
2 weeks ago • Google News
89bio Inc (ETNB)
US$ 8.3510.74%
Price Chart
Key Statistics
Market Cap
$ 1.4B
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
2.42M
52W High
$ 11.84
52W Low
$ 4.16
Dividend Yield
0.00%
Beta
1.47
Technicals
50-Day MA
7.4639
200-Day MA
8.1913
52 Week High
11.84
52 Week Low
4.16
About ETNB
89bio, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases.
Employees
93
Headquarters
San Francisco, CA
CEO
Mr. Rohan Palekar
Latest News
Why 89bio, Inc. (ETNB) Is Among the Best Low Priced Biotech Stocks to Buy Now - Yahoo Finance
2 weeks ago • Google News
89bio: A Buy With Strong Market Opportunity In MASH And SHTG - Seeking Alpha
2025-04-18 • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg